Updates are available Correction dated 2024-10-05
Click to view Correction: https://doi.org/10.1007/s13555-024-01276-z
-
Authors
Ameen, Ahmed https://orcid.org/0009-0002-7371-4509
Dhaheri, Ahmed Al
Reda, Ashraf M.
Alnaeem, Ayman
Marzooqi, Fatima Al https://orcid.org/0009-0002-4724-8225
Albreiki, Fatima https://orcid.org/0009-0003-8831-0969
Ali, Huda Rajab
Dayem, Hussein Abdel
Alnaqbi, Jawaher
Zaabi, Mariam Al
Ahmed, Mohammed
Stingl, Georg https://orcid.org/0000-0003-3843-7841
Murrawi, Muna Al
-
Funding
Funding for this research was provided by:
Emirates Dermatological Society.
- License Information
-
More Information
Article History
Received: 7 June 2024
Accepted: 26 July 2024
First Online: 22 August 2024
Change Date: 5 October 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s13555-024-01276-z
Declarations
:
: Ahmed Ameen has received honorarium as speaker and/or advisor and/or principal investigator from AbbVie, Ego Pharma, Galderma, Janssen, LEO Pharma, Lilly, Novartis, Pfizer, and Sanofi. Hussein Abdel Dayem has received honoraria from Abbvie, Eli Lilly, Janssen, Medpharma, Novartis, Pfizer, Sanofi, and UCB. Georg Stingl has received consultation and/or lecture fees from Almirall, AOP Health, Boehringer Ingelheim, Bristol Myers Squibb, Evommune, LEO Pharma, Lilly, Marinomed AG, Novartis, and Sanofi/Regeneron. Ahmed Al Dhaheri, Ashraf M. Reda, Ayman Alnaeem, Fatima Al Marzooqi, Fatima Albreiki, Huda Rajab Ali, Jawaher Alnaqbi, Mariam Al Zaabi, Mohammed Ahmed, and Muna Al Murrawi have no conflicts of interest to declare.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors. Ethical approval was not required.
